Where does ArQule Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ArQule Inc. ranks #12,354 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ArQule Inc. hold?

ArQule Inc. holds 24 US utility patents granted between 2015 and 2022, spanning 10 technology areas.

What is ArQule Inc.'s Innovation Score?

ArQule Inc. has an Innovation Score of 34.3 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ArQule Inc. focus on?

ArQule Inc.'s top technology area is C07D (Heterocyclic Compounds) with 21 patents, ranking #419 of 3,165 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is ArQule Inc.'s patent grant rate increasing or decreasing?

ArQule Inc.'s recent grant velocity is -59% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ArQule Inc.'s patents?

ArQule Inc.'s patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ArQule Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ArQule Inc.

USPTO PatentsView assignee record - 24 granted patents across 10 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arqule ranks #12,354 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 10 technology areas.

#12,354
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.3/100): 18.6
avg claims per patent: -59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12354 · US Corporation #12,354 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 24 grants
UPPER-Q #12,354/49,997
PHOTO-FINISH Ameriglobe
CPC-FOCUS C07D · 10 areas
INNOV-THIN 34.3/100
CLAIMS-RICH 18.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ameriglobe, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arqule’s 34.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (32%) Velocity 0.8 pts (2%) Breadth 11.2 pts (33%) Claim depth 11.2 pts (33%)

Qualcomm Incorporated · highest

85
ArQule · this assignee

34
3D Lighting… · lowest

7

What this shows Arqule's Innovation Score is 34.3/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arqule?

Each dot is one of Arqule’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arqule’s own 18.6 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arqule vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arqule's grants concentrate

ArQule Inc. is a focused PatentsView assignee: 10 CPC subclasses with 87.5% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2022. By volume, Arqule sits between Ameriglobe, LLC and Arçelik Anonim Sirketi.

Arqule's three-year grant acceleration

ArQule Inc. shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ameriglobe

24
Amprius

24
Anonyome Labs

24
Apellis Pharmaceu…

24
Archem

24
Archroma IP

24
Arkade

24
Arçelik Anonim Si…

24
Arqule ◀

24

What this shows ArQule holds 24 patents at rank #12,355, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ArQule

By rank, the assignees closest to #12,355 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in ArQule's primary technology class.

Arqule's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ArQule Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	16.7%
2016	4	16.7%
2017	4	16.7%
2018	3	12.5%
2019	2	8.3%
2020	2	8.3%
2021	4	16.7%
2022	1	4.2%

Which technologies does ArQule Inc. patent most?

C07D - Heterocyclic Compounds 21

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 9

Y02A - Technologies FOR Adaptation TO Climate Change 4

C07C - Acyclic OR Carbocyclic Compounds 1

Y10T - Technical Subjects Covered BY Former US Classification 1

C07K - Peptides 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ArQule Inc.'s patent record in context - here's where to go next.

ArQule Inc.'s lead technology class is C07D (Heterocyclic Compounds), 87.5% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #12,354 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ArQule Inc. against Ameriglobe, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.